CD8A and neoplasm: During treatment with CHL, mice also received oral lithium carbonate (LC) therapy, which transformed lactate, a byproduct of tumor metabolism, into a valuable energy source for CD8+ T cells, thus enhancing the efficacy of CHL‐mediated photoimmunotherapy.